Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 5
Submit an article Journal homepage
1,765
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card

Simon de LusignanDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8553-2641View further author information
ORCID Icon,
Filipa FerreiraDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKORCID Iconhttps://orcid.org/0000-0002-7717-8486View further author information
ORCID Icon,
Silvia DamasoBiostatistics EPI, GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0003-4851-4396View further author information
ORCID Icon,
Rachel ByfordDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKORCID Iconhttps://orcid.org/0000-0002-4792-8995View further author information
ORCID Icon,
Sameera PathirannehelageDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKORCID Iconhttps://orcid.org/0000-0002-5112-8296View further author information
ORCID Icon,
Anne YeakeyClinical Safety & Pharmacovigilance, GSK, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0003-3691-3445View further author information
ORCID Icon,
Ivelina YonovaDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKORCID Iconhttps://orcid.org/0000-0003-4856-3075View further author information
ORCID Icon,
Anne SchuindClinical R&D, GSK, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0003-3544-0682View further author information
ORCID Icon &
Gael Dos SantosClinical R&D, GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0001-8623-3478View further author information
ORCID Icon show all
Pages 1048-1059 | Received 12 Jul 2018, Accepted 27 Dec 2018, Published online: 20 Mar 2019

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Laurence Serradell, Sophie Wagué, Annick Moureau, Markku Nissilä & Anne-Laure Chabanon. (2021) Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season. Human Vaccines & Immunotherapeutics 17:4, pages 1205-1210.
Read now
Simon de Lusignan, Silvia Damaso, Filipa Ferreira, Rachel Byford, Christopher McGee, Sameera Pathirannehelage, Vishvesh Shende, Ivelina Yonova, Alexander Schmidt, Anne Schuind & Gael Dos Santos. (2020) Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season. Human Vaccines & Immunotherapeutics 16:8, pages 1762-1771.
Read now
Gaël Dos Santos. (2019) Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives. Human Vaccines & Immunotherapeutics 15:11, pages 2624-2636.
Read now

Articles from other publishers (14)

Sooin Choi, Soo Jeong Choi, Jin Kuk Kim, Yong-Wha Lee & You Kyoung Lee. (2023) Real-World Evidence of Point-of-Care Glucometers: Enhanced Passive Surveillance and Adverse Event Reporting Status in Korea and the United States. Annals of Laboratory Medicine 43:5, pages 515-519.
Crossref
Gaël Dos Santos, Tamara Eckermann, Xavier Martínez‐Gómez, Jose Parra, Ugo Nwoji & Ignacio Salamanca de la Cueva. (2023) Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring. Influenza and Other Respiratory Viruses 17:3.
Crossref
Melanie Moeller-Arendt, Serge van de Witte, Jos Nauta, Hanka de Voogd, Jutta Rogoll & Thomas Nisslein. (2023) Enhanced passive safety surveillance of Influvac® and Influvac® Tetra: Results from seven consecutive seasons. Vaccine 41:2, pages 606-613.
Crossref
Ko Eun Doo, Jeongyeon Seok, Yoon Sook Cho, Yun Hee Jo, Rae Young Kang, Hyun Jee Kim, Hyunjung Jin, Soyoung Park, Minjung Choi, Youngeun Seo, Bo Kyung Moon, Jihong Choi, Min-Gyu Kang, Min Kyoung Kang, Mi Na Min, Woo Kyung Kim, Kyun Hwa Kang, Kyung Eun Lee, Sujin Kim, Jaechun Lee, Yunhee Kim, Hongtae Kim, Ki Dong Yu, Yoon Yee Seo, Kyung Un Lee, Hyun-A Sohn, Young Hee Lee, Young Mi Ah & Ju-Yeun Lee. (2022) A Survey on Hospital Systems for Adverse Drug Event (ADE) History Information Sharing, Intervention, and Drug Safety Card Issue. Journal of Korean Society of Health-System Pharmacists 39:3, pages 326-340.
Crossref
Simon de Lusignan, Ruby S M Tsang, Oluwafunmi Akinyemi, Jamie Lopez Bernal, Gayatri Amirthalingam, Julian Sherlock, Gillian Smith, Maria Zambon, Gary Howsam & Mark Joy. (2022) Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study. JMIR Public Health and Surveillance 8:3, pages e25803.
Crossref
Gaël Dos Santos, Hao Wang, Pooja Jindal, Maria Rybo, Hélène Roul, Sridevi Pallem, Tamara Eckermann, Lode Godderis, Xavier Martínez Gómez, Eric Godard, Muriel Soler, Mitra Yousefi, Ignacio Salamanca de la Cueva & Ugo Nwoji. (2021) Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season. Infectious Diseases and Therapy 11:1, pages 463-483.
Crossref
Ignacio Salamanca de la Cueva, Elisa Cinconze, Tamara Eckermann, Ugo Nwoji, Lode Godderis, Emily Lu, Xavier Martínez-Gómez, Huajun Wang & Emad Yanni. (2021) Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season. Drug Safety 44:12, pages 1375-1390.
Crossref
Simon de Lusignan, Jamie Lopez Bernal, Rachel Byford, Gayatri Amirthalingam, Filipa Ferreira, Oluwafunmi Akinyemi, Nick Andrews, Helen Campbell, Gavin Dabrera, Alexandra Deeks, Alex J Elliot, Else Krajenbrink, Harshana Liyanage, Dylan McGagh, Cecilia Okusi, Vaishnavi Parimalanathan, Mary Ramsay, Gillian Smith, Manasa Tripathy, John Williams, William Victor, Maria Zambon, Gary Howsam, Brian David Nicholson, Victoria Tzortziou Brown, Christopher C Butler, Mark Joy & FD Richard Hobbs. (2021) Influenza and Respiratory Virus Surveillance, Vaccine Uptake, and Effectiveness at a Time of Cocirculating COVID-19: Protocol for the English Primary Care Sentinel System for 2020-2021. JMIR Public Health and Surveillance 7:2, pages e24341.
Crossref
Vaishnavi Parimalanathan, Mark Joy, Pieter Jan Van Dam, Xuejuan Fan & Simon de Lusignan. (2021) Association between Influenza Vaccine Administration and Primary Care Consultations for Respiratory Infections: Sentinel Network Study of Five Seasons (2014/2015–2018/2019) in the UK. International Journal of Environmental Research and Public Health 18:2, pages 523.
Crossref
Kaatje Bollaerts, Tom de Smedt, Chris McGee, Hanne-Dorthe Emborg, Marco Villa, Maria Alexandridou, Talita Duarte-Salles, Rosa Gini, Claudia Bartolini, Simon de Lusignan, Myint Tin Tin Htar, Lina Titievsky, Miriam Sturkenboom & Vincent Bauchau. (2020) ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases. Vaccine 38, pages B76-B83.
Crossref
Ashwin Kamath, Nivedita Maity & Manel Arjun Nayak. (2020) Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database. Clinical Drug Investigation 40:9, pages 883-889.
Crossref
Joe W. Cross, Mark Joy, Christopher McGee, Oluwafunmi Akinyemi, Piers Gatenby & Simon de Lusignan. (2020) Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010–2018). Vaccine 38:22, pages 3869-3880.
Crossref
Gael Dos Santos, Bach-Yen Nguyen, Silvia Damaso, Lode Godderis, Xavier Martínez-Gómez, Tamara Eckermann, Hugo Loos, Ignacio Salamanca de la Cueva, Vishvesh Shende, Alexander C. Schmidt & Anne Yeakey. (2019) Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season. Drug Safety 43:3, pages 265-279.
Crossref
Gael Dos Santos, Vishvesh Shende, Silvia Damaso & Anne Yeakey. (2019) Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis. Advances in Therapy 36:12, pages 3340-3355.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.